Among the proteins in the cerebrospinal fluid, the researchers identified biomarkers that can accurately predict the development of ICANS. Specifically, two characteristic proteins, C1RL and FUCA2, ...
Selecting the right biomarkers is important for success in phase transition of clinical trials. Spatial phenotyping has increasingly allowed us to select high-quality protein biomarkers that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback